Literature DB >> 18322667

[A 52-year-old woman with acute shock and purpura fulminans. Pneumococcal sepsis].

E Jochum1, A Perez-Bouza, S Baumanns, J vom Dahl, U Janssen.   

Abstract

We report a 52-year-old female patient admitted with fever, chills, and myalgias since the previous day. On the day of admission she had a generalized seizure. The patient had no previous illnesses. Laboratory investigations showed consumptive coagulopathy with clinical manifestations of shock and development of multiple organ failure. Pneumococci were detected in blood cultures. Furthermore the skin showed purpura fulminans all over. The patient died within 24 h after admission in the intensive care unit. On autopsy, in addition to adrenal and myocardial hemorrhages, hypoplasia of the spleen was found. Fulminant pneumococcal sepsis is a life-threatening disease that occurs in patients with risk factors like splenic hypoplasia or asplenia. Sometimes a fulminant pneumococcal sepsis may be the first clinical manifestation of a hitherto unknown splenic hypoplasia. In this context the general recommendation of vaccination against pneumococci in patients with risk factors like splenic hypoplasia or asplenia, in patients older than 60, and in children from 2 months onward has to be emphasized.

Entities:  

Mesh:

Year:  2008        PMID: 18322667     DOI: 10.1007/s00108-008-2039-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  14 in total

1.  Lethal pneumococcal infection in an 18-month-old girl with splenic hypoplasia and dysgammaglobulinemia.

Authors:  R Nanan; K Peters; L Schrod; H W Kreth
Journal:  Ann Hematol       Date:  2001-11       Impact factor: 3.673

2.  Overwhelming postsplenectomy infection.

Authors:  W Krivit
Journal:  Am J Hematol       Date:  1977       Impact factor: 10.047

Review 3.  The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto.

Authors:  Victoria E Price; Sanjeev Dutta; Victor S Blanchette; Sheila Butchart; Melanie Kirby; Jacob C Langer; E Lee Ford-Jones
Journal:  Pediatr Blood Cancer       Date:  2006-05-01       Impact factor: 3.167

Review 4.  Infections and immunizations of children with sickle cell disease.

Authors:  G D Overturf
Journal:  Adv Pediatr Infect Dis       Date:  1999

Review 5.  Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited.

Authors:  K Hansen; D B Singer
Journal:  Pediatr Dev Pathol       Date:  2001 Mar-Apr

Review 6.  Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis, and vaccination.

Authors:  W Y Wong; G D Overturf; D R Powars
Journal:  Clin Infect Dis       Date:  1992-05       Impact factor: 9.079

7.  Host defense against Streptococcus pneumoniae: the role of the spleen.

Authors:  D W Wara
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

8.  [Asplenia and hyposplenism].

Authors:  J Beytout; O Tournilhac; H Laurichesse
Journal:  Presse Med       Date:  2003-09-06       Impact factor: 1.228

9.  Relapsing systemic infection due to Rhodococcus equi in a drug abuser seropositive for human immunodeficiency virus.

Authors:  G Sirera; J Romeu; B Clotet; P Velasco; J Arnal; F Rius; M Foz
Journal:  Rev Infect Dis       Date:  1991 May-Jun

10.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

View more
  2 in total

1.  Purpura fulminans in a patient with mixed connective tissue disease.

Authors:  Aizuri A Murad; Michael Jeffers; Anne-Marie Tobin; Maureen Connolly
Journal:  BMJ Case Rep       Date:  2013-01-30

2.  A Rare Association of Congenital Asplenia with Jejunal Arteriovenous Malformation.

Authors:  Jelena Z Arnautovic; Areej Mazhar; Stela Tereziu; Kashvi Gupta
Journal:  Am J Case Rep       Date:  2017-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.